Works matching DE "RECOMBINANT drugs"

Results: 102
    1
    2
    3
    4

    Neuromodulation for Brain Tumors: Myth or Reality? A Narrative Review.

    Published in:
    International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11738, doi. 10.3390/ijms241411738
    By:
    • D'Alessandris, Quintino Giorgio;
    • Menna, Grazia;
    • Izzo, Alessandro;
    • D'Ercole, Manuela;
    • Della Pepa, Giuseppe Maria;
    • Lauretti, Liverana;
    • Pallini, Roberto;
    • Olivi, Alessandro;
    • Montano, Nicola
    Publication type:
    Article
    5

    The Increase in the Drug Resistance of Acute Myeloid Leukemia THP-1 Cells in High-Density Cell Culture Is Associated with Inflammatory-like Activation and Anti-Apoptotic Bcl-2 Proteins.

    Published in:
    International Journal of Molecular Sciences, 2022, v. 23, n. 14, p. 7881, doi. 10.3390/ijms23147881
    By:
    • Kobyakova, Margarita;
    • Lomovskaya, Yana;
    • Senotov, Anatoly;
    • Lomovsky, Alexey;
    • Minaychev, Vladislav;
    • Fadeeva, Irina;
    • Shtatnova, Daria;
    • Krasnov, Kirill;
    • Zvyagina, Alena;
    • Odinokova, Irina;
    • Akatov, Vladimir;
    • Fadeev, Roman
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies.

    Published in:
    Haemophilia, 2019, v. 25, n. 3, p. 398, doi. 10.1111/hae.13747
    By:
    • Volkers, Peter;
    • Hanschmann, Kay‐Martin;
    • Keller‐Stanislawski, Brigitte;
    • Palmer, Ben P.;
    • Santagostino, Elena;
    • van Hardeveld, Ella M.;
    • van den Berg, Marijke;
    • Calvez, Thierry;
    • Chambost, Hervé;
    • Collins, Peter W.;
    • Demiguel, Virginie;
    • Hart, Daniel P.;
    • Hay, Charles R.M.;
    • Goudemand, Jenny;
    • Ljung, Rolf
    Publication type:
    Article
    24
    25
    26

    Immunogenicity, efficacy and safety of Nuwiq<sup>®</sup> (human‐cl rhFVIII) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect Study.

    Published in:
    Haemophilia, 2018, v. 24, n. 2, p. 211, doi. 10.1111/hae.13320
    By:
    • Liesner, R. J.;
    • Dubey, L.;
    • Ducore, J.;
    • Fouzia, N. A.;
    • Gattens, M.;
    • Gruel, Y.;
    • Guillet, B.;
    • Kavardakova, N.;
    • El Khorassani, M.;
    • Klukowska, A.;
    • Lambert, T.;
    • Abashidze, M.;
    • Lohade, S.;
    • Sigaud, M.;
    • Turea, V.;
    • Wu, J. K. M.;
    • Vdovin, V.;
    • Pavlova, A.;
    • Jansen, M.;
    • Belyanskaya, L.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Pharmaceutical Biotechnology.

    Published in:
    Life (2075-1729), 2022, v. 12, n. 8, p. 1240, doi. 10.3390/life12081240
    By:
    • Roque-Borda, Cesar Augusto;
    • Pavan, Fernando Rogério;
    • Meneguin, Andréía Bagliotti
    Publication type:
    Article
    47
    48
    49
    50

    MODERN THERAPEUTIC APPROACHES IN FOOD ALLERGY.

    Published in:
    Romanian Journal of Pediatrics / Revista Romana de Pediatrie, 2013, v. 62, n. 4, p. 334, doi. 10.37897/rjp.2013.4.1
    By:
    • Alexoae, Monica;
    • Gotia, Stela;
    • Ioniuc, Ileana
    Publication type:
    Article